Therapy Areas: AIDS & HIV
6 February 2024 - Biopharmaceutical company GSK plc (LSE/NYSE: GSK) said on Tuesday that the Center for Drug Evaluation (CDE) of the China National Medical Products Administration (NMPA) has accepted ...
29 January 2024 - Biopharmaceutical company Takeda (TSE:4502) (NYSE:TAK) announced on Monday that HyQvia [Immune Globulin Infusion 10% (Human) with Recombinant Human Hyaluronidase] has been approved i...
23 January 2024 - Allurion Technologies Inc (NYSE: ALUR), a company focussed on ending obesity, announced on Tuesday that Somerset NHS Foundation Trust (FT) has pioneers the use of the company's ...
16 January 2024 - Biopharmaceutical company Takeda (TSE:4502) (NYSE:TAK) said on Tuesday that it has secured US Food and Drug Administration (FDA) approval for HYQVIA (Immune Globulin Infusion 10% [Hu...
2 January 2024 - UK-based liquid biopsy company ANGLE plc (AIM:AGL) (OTCQX:ANPCY) announced on Tuesday that it has secured a contract with Japanese pharmaceutical company Eisai (TYO:4523).Valued at US...
20 December 2023 - genedrive plc (AIM: GDR), a point-of-care pharmacogenetic testing company, announced on Wednesday that it has received initial orders for its Genedrive MT-RNR1 products from France,...